Bausch + Lomb gives up on glaucoma eye drop hopeful after phase 2 fail Read more →

Fierce Biotech Fundraising Tracker '26: MindRank rakes in $52M to advance phase 3-stage oral GLP-1 Read more →

ARPA-H awards up to $160M to scientists developing custom genetic medicines Read more →